Participation Lp Sfm, 10% Owner at MAP Pharmaceuticals, Inc. (MAPP), sold 35,847 shares at $14.09 ($501K) on 2010-03-04, disclosed to the SEC on 2010-03-08.
Open-market sale of $501k MAPP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.09 | 97 | $1K | 0.3% |
| 2 | $14.15 | 677 | $10K | 1.9% |
| 3 | $14.15 | 3,061 | $43K | 8.6% |
| 4 | $13.95 | 4,616 | $64K | 12.9% |
| 5 | $13.95 | 6,524 | $91K | 18.2% |
| 6 | $13.95 | 20,872 |
| $291K |
| 58.1% |
| Total | $13.97 avg | 35,847 | $501K | 100% |